search
Back to results

Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness

Primary Purpose

Mental Illness Persistent, Cardiovascular Prevention

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Cardiac Rehabilitation Program
Sponsored by
Lady Davis Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Mental Illness Persistent focused on measuring Severe and persistent mental illness, Primary prevention, Measures, Schizophrenia, Schizoaffective disorder, Bipolar disorder

Eligibility Criteria

30 Years - 59 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Age ≥ 30 to 59 years old Psychiatric diagnosis of schizophrenia, schizoaffective disorder, or bipolar I disorder 2 or more cardiac risk behaviors or conditions: smoking, obese, hypertension, diabetes, metabolic syndrome, dyslipidemia, obstructive sleep apnea 10-year Framingham cardiovascular risk score of ≥ 10% (intermediate risk) Willing to participate in cardiac rehabilitation program Exclusion Criteria: Psychiatric instability, as judged by treating psychiatrist Distance from cardiac rehabilitation centre that would preclude participation Unsafe to participate in the cardiac rehabilitation intervention, as judged by the cardiology assessment Pregnant Known coronary artery disease, cerebrovascular disease, or peripheral vascular disease Court ordered mandatory or tutor

Sites / Locations

  • Jewish General Hospital/Lady Davis InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

The standard cardiac rehabilitation program consists of the following: a (1) consultation with a kinesiologist to assess level of fitness and to prepare an individually customized exercise plan, (2) consultation with a dietitian to guide the participant with healthy nutrition choices, (3) on site supervised and/or virtual exercise sessions with gradual elaboration of a home program, (4) weekly educational capsules and monthly workshops related to cardiac health, and, (5) if deemed necessary by the treating team, consultation with a psychologist, an occupational therapist, a physiotherapist, or a social worker.

Participants in the control group will receive educational information on maintaining optimal cardiovascular health. Participants will be encouraged to undergo 30 minutes of moderate-intensity aerobic activity at least 5 days per week. Participants will be given educational materials on recommended diet and exercise.

Outcomes

Primary Outcome Measures

Efficacy outcome
10-year Framingham cardiovascular risk score

Secondary Outcome Measures

30-year Cardiovascular risk
30-year Framingham cardiovascular risk score
PRIMROSE BMI risk score
PRIMROSE BMI risk score
PRIMROSE Lipid risk score
PRIMROSE Lipid risk score
Quality of life
EQ-5D-5L

Full Information

First Posted
December 5, 2022
Last Updated
March 8, 2023
Sponsor
Lady Davis Institute
Collaborators
Jewish General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05659498
Brief Title
Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness
Official Title
Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness: A Pilot Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 14, 2022 (Actual)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Lady Davis Institute
Collaborators
Jewish General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this prospective, randomized trial is to explore the link between cardiovascular disease and mortality in individuals with severe and persistent mental illness (SPMI). The main question it aims to answer is: Is a primary prevention cardiac rehabilitation intervention feasible and effective at reducing cardiovascular risk in people with a primary psychotic disorder or bipolar disorder?" Participants will undergo a multi-component primary prevention intervention program. Researchers will compare with a control group to see if cardiovascular risk reduction is attained.
Detailed Description
This prospective, randomized study aims to recruit 46 adults with schizophrenia, schizoaffective disorder, or bipolar disorder, who are classified as intermediate or high 10-year risk for a cardiovascular event, into a multi-component cardiac rehabilitation intervention program. The aim is to explore the feasibility and efficacy of this multi-component primary prevention intervention program in reducing cardiovascular risk in individuals with SPMI. Evidence supports a high burden of cardiovascular disease and mortality in individuals with SPMI. In link, multiple studies outline disparities in access to quality cardiovascular care in people with SPMI. Given the high CV risk factor burden in people with SPMI and the disparity in access and quality of care, there is a need to screen for CV risk factors and initiate and monitor guideline-directed therapies in people with SPMI. Intervention outcomes will be measured using the Framingham 10-year cardiovascular risk score, the Framingham 30-year cardiovascular risk score, the PRIMOSE BMI and Lipid risk scores, the EQ-5D-5L scale and the CGI score. Continuous variables will be displayed as means, with associated standard deviations. Categorical variables will be represented as frequencies and percentages. Subsequent comparative analysis will take place, where the overall cohort will be characterized into high risk (top quartile) and low risk (bottom quartile) cohorts. This will be accomplished using the chi-squared test or the Fisher exact test, along with the student's t test and the Mann-Whitney U test when appropriate. SPSS 24.0 will be the statistical software used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mental Illness Persistent, Cardiovascular Prevention
Keywords
Severe and persistent mental illness, Primary prevention, Measures, Schizophrenia, Schizoaffective disorder, Bipolar disorder

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Masking the participant and provider is not possible due to the nature of the intervention
Allocation
Randomized
Enrollment
46 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
The standard cardiac rehabilitation program consists of the following: a (1) consultation with a kinesiologist to assess level of fitness and to prepare an individually customized exercise plan, (2) consultation with a dietitian to guide the participant with healthy nutrition choices, (3) on site supervised and/or virtual exercise sessions with gradual elaboration of a home program, (4) weekly educational capsules and monthly workshops related to cardiac health, and, (5) if deemed necessary by the treating team, consultation with a psychologist, an occupational therapist, a physiotherapist, or a social worker.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Participants in the control group will receive educational information on maintaining optimal cardiovascular health. Participants will be encouraged to undergo 30 minutes of moderate-intensity aerobic activity at least 5 days per week. Participants will be given educational materials on recommended diet and exercise.
Intervention Type
Behavioral
Intervention Name(s)
Cardiac Rehabilitation Program
Intervention Description
The standard cardiac rehabilitation program consists of the following: a (1) consultation with a kinesiologist to assess level of fitness and to prepare an individually customized exercise plan, (2) consultation with a dietitian to guide the participant with healthy nutrition choices, (3) on site supervised and/or virtual exercise sessions with gradual elaboration of a home program, (4) weekly educational capsules and monthly workshops related to cardiac health, and, (5) if deemed necessary by the treating team, consultation with a psychologist, an occupational therapist, a physiotherapist, or a social worker.
Primary Outcome Measure Information:
Title
Efficacy outcome
Description
10-year Framingham cardiovascular risk score
Time Frame
9 months
Secondary Outcome Measure Information:
Title
30-year Cardiovascular risk
Description
30-year Framingham cardiovascular risk score
Time Frame
9 months
Title
PRIMROSE BMI risk score
Description
PRIMROSE BMI risk score
Time Frame
9 months
Title
PRIMROSE Lipid risk score
Description
PRIMROSE Lipid risk score
Time Frame
9 months
Title
Quality of life
Description
EQ-5D-5L
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age ≥ 30 to 59 years old Psychiatric diagnosis of schizophrenia, schizoaffective disorder, or bipolar I disorder 2 or more cardiac risk behaviors or conditions: smoking, obese, hypertension, diabetes, metabolic syndrome, dyslipidemia, obstructive sleep apnea 10-year Framingham cardiovascular risk score of ≥ 10% (intermediate risk) Willing to participate in cardiac rehabilitation program Exclusion Criteria: Psychiatric instability, as judged by treating psychiatrist Distance from cardiac rehabilitation centre that would preclude participation Unsafe to participate in the cardiac rehabilitation intervention, as judged by the cardiology assessment Pregnant Known coronary artery disease, cerebrovascular disease, or peripheral vascular disease Court ordered mandatory or tutor
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael J Goldfarb, MD MSc
Phone
5143408222
Email
michael.j.goldfarb@mcgill.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael J Goldfarb
Organizational Affiliation
Lady Davis Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Jewish General Hospital/Lady Davis Institute
City
Montréal
State/Province
Quebec
ZIP/Postal Code
H3T 1E2
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael J Goldfarb, MD MSc
Phone
514-340-8222
Email
michael.j.goldfarb@mcgill.ca

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32530472
Citation
Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AE, Cather C, Jerome GJ, Young DR, Charleston JB, Gennusa JV 3rd, Goldsholl S, Cook C, Heller A, McGinty EE, Crum RM, Appel LJ, Wang NY. Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 1;3(6):e207247. doi: 10.1001/jamanetworkopen.2020.7247.
Results Reference
background
PubMed Identifier
33128044
Citation
Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2021 Feb;18(2):136-145. doi: 10.1038/s41569-020-00463-7. Epub 2020 Oct 30.
Results Reference
background
PubMed Identifier
36007991
Citation
Goldfarb M, De Hert M, Detraux J, Di Palo K, Munir H, Music S, Pina I, Ringen PA. Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Aug 30;80(9):918-933. doi: 10.1016/j.jacc.2022.06.017.
Results Reference
background

Learn more about this trial

Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness

We'll reach out to this number within 24 hrs